These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22134570)

  • 1. Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.
    Maiti R; Jaida J; Raghavendra BN; Goud P; Ahmed I; Palani A
    J Drugs Dermatol; 2011 Dec; 10(12):1444-50. PubMed ID: 22134570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R; Rahman J; Jaida J; Allala U; Palani A
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
    Gimenez-Arnau A; Pujol RM; Ianosi S; Kaszuba A; Malbran A; Poop G; Donado E; Perez I; Izquierdo I; Arnaiz E;
    Allergy; 2007 May; 62(5):539-46. PubMed ID: 17441794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
    Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
    Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
    Giménez-Arnau A; Izquierdo I; Maurer M
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
    Garg G; Thami GP
    J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
    Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.
    Metz M; Scholz E; Ferrán M; Izquierdo I; Giménez-Arnau A; Maurer M
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):86-92. PubMed ID: 20143651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
    Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
    Segall N; Gawchik S; Georges G; Haeusler JM
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
    Grob JJ; Lachapelle JM
    Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
    Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
    Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
    Picado C
    Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.